• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Cumulative number of Civil Money Penalties filed for the FY against Tobacco Retailers (excluding internet based)

Dictionary: The Family Smoking Prevention and Tobacco Control Act amended the Federal Food, Drug, and Cosmetic Act and provided the FDA with a broad set of sanctions for violations of the law. Such sanctions may include: warning letter, civil money penalty, import alert, seizure, injunction, and criminal prosecution.

Civil Money Penalties are assessed against tobacco product retailers not in compliance with tobacco product requirements. For more information about the agency’s current policies with respect to civil money penalties for retailers who are in violation, please see CTP’s website Guidance, Compliance & Regulatory Information, to find the guidance entitled, “Guidance for FDA and Tobacco Retailers Civil Money Penalties and No-Tobacco-Sale Orders For Tobacco Retailers.”

Information is current as of March 30, 2013

Fiscal Year - 2014

Skip graphic and jump to text data

TimeTargetNumber
Oct 2013N/A98
Nov 2013N/A166
Dec 2013N/A246
Jan 2014N/A326
Feb 2014N/A399
Mar 2014N/A428
Apr 2014N/ATBD
May 2014N/ATBD
Jun 2014N/ATBD
Jul 2014N/ATBD
Aug 2014N/ATBD
Sep 2014N/ATBD

FY 2014 YTD: 428

Number of Civil Money Penalties filed in the month against Tobacco Retailers (excluding internet based)

Fiscal Year - 2014
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2013N/A98
Nov 2013N/A68
Dec 2013N/A80
Jan 2014N/A80
Feb 2014N/A73
Mar 2014N/A29
Apr 2014N/ATBD
May 2014N/ATBD
Jun 2014N/ATBD
Jul 2014N/ATBD
Aug 2014N/ATBD
Sep 2014N/ATBD

FY 2014 YTD: 428

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.